Company Filing History:
2 out of 33 
1 out of 1 
1 out of 111 Years Active: 1996-2000
Title: The Innovative Contributions of Christopher P Prior
Introduction
Christopher P Prior is a notable inventor based in Wayne, PA (US), recognized for his significant contributions to the field of biotechnology. With a total of 4 patents, Prior has made strides in the production and purification of viral particles, as well as in therapeutic applications related to von Willebrand factor.
Latest Patents
One of Prior's latest patents focuses on the highly efficient production and isolation of viral particles. This invention outlines a continuous process for producing viral particles by utilizing a perfused growth medium containing viable virally infected non-lytic cells. The process involves removing the medium at a rate that maintains the steady-state log-phase growth of the remaining cells. Additionally, Prior has developed a method for purifying retroviral particles, which includes passing a solution through an anion exchange resin and eluting the retroviral particles from the resin. Another significant patent involves therapeutic fragments of von Willebrand factor, detailing processes for preparing aqueous solutions of cysteine-altered von Willebrand Factor fragments that are free of aggregates and suitable for treating thrombosis.
Career Highlights
Throughout his career, Christopher P Prior has worked with various organizations, including The Immune Response Corporation and Centeon LLC. His work has significantly impacted the biotechnology sector, particularly in the development of processes that enhance the efficiency and effectiveness of viral particle production and purification.
Collaborations
Prior has collaborated with notable professionals in his field, including Michael E Hrinda and David L Farb. These collaborations have contributed to the advancement of his innovative projects and patents.
Conclusion
Christopher P Prior's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in therapeutic applications and viral particle production.